Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

CASE REPORT
[View FULLTEXT] [Download PDF
 
Year : 2013  |  Volume : 59  |  Issue : 1  |  Page : 54-55  

Clozapine re-challenge under the cover of Filgrastim

R Gopalakrishnan, TP Subhalakshmi, A Kuruvilla, KS Jacob 
 Department of Psychiatry, Christian Medical College, Bagayam, Vellore, Tamil Nadu, India

Correspondence Address:
R Gopalakrishnan
Department of Psychiatry, Christian Medical College, Bagayam, Vellore, Tamil Nadu
India

Rechallenge with clozapine, despite a history of clozapine-induced neutropenia is considered in patients with a good response to the drug in the past, for whom no other treatments are effective, and in cases where the risks of withholding treatment are greater than the risks of rechallenge. Dyscrasias that occur during rechallenge are reportedly earlier in onset and longer lasting. Strategies advocated during rechallenge include frequent monitoring of white blood counts, the use of lithium or Granulocyte-Colony Stimulating Factors. We report a case of a patient with treatment-resistant schizophrenia who developed neutropenia with clozapine as a result of which the drug was discontinued. However poor response to other first and second-generation antipsychotic medication and the persisting risk of harm to himself and others necessitated the reconsideration of clozapine. The patient was re-challenged with clozapine under the cover of Filgrastim, a Granulocyte-Colony Stimulating Factor.


How to cite this article:
Gopalakrishnan R, Subhalakshmi T P, Kuruvilla A, Jacob K S. Clozapine re-challenge under the cover of Filgrastim.J Postgrad Med 2013;59:54-55


How to cite this URL:
Gopalakrishnan R, Subhalakshmi T P, Kuruvilla A, Jacob K S. Clozapine re-challenge under the cover of Filgrastim. J Postgrad Med [serial online] 2013 [cited 2021 Jun 21 ];59:54-55
Available from: https://www.jpgmonline.com/article.asp?issn=0022-3859;year=2013;volume=59;issue=1;spage=54;epage=55;aulast=Gopalakrishnan;type=0


 
Monday, June 21, 2021
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer